Clinical Review Extracts from “Clinical Evidence”: Pelvic inflammatory disease BMJ 2001; 322 doi: https://doi.org/10.1136/bmj.322.7287.658 (Published 17 March 2001) Cite this as: BMJ 2001;322:658 Article Related content Metrics Responses Peer review Related articles No related articles found. See more An adolescent with disabling abdominal pain BMJ December 07, 2016, 355 i6101; DOI: https://doi.org/10.1136/bmj.i6101 What it feels like to be an interesting teaching opportunity BMJ December 07, 2016, 355 i6190; DOI: https://doi.org/10.1136/bmj.i6190 Johnson & Johnson is ordered to pay $1bn over faulty hip implants BMJ December 06, 2016, 355 i6551; DOI: https://doi.org/10.1136/bmj.i6551 Shared decision making in patients with low risk chest pain: prospective randomized pragmatic trial BMJ December 05, 2016, 355 i6165; DOI: https://doi.org/10.1136/bmj.i6165 Generics have a chequered recent history BMJ December 05, 2016, 355 i6527; DOI: https://doi.org/10.1136/bmj.i6527 Cited by... Moxifloxacin versus ofloxacin plus metronidazole in uncomplicated pelvic inflammatory disease: results of a multicentre, double blind, randomised trialAbstract Fulltext PDF Improvement in the clinical cure rate of outpatient management of pelvic inflammatory disease following a change in therapyAbstract Fulltext PDF Diagnosis of pelvic inflammatory disease: time for a rethinkAbstract Fulltext PDF
